Post by Africa Investor Review

ENDRA Life Sciences (Nasdaq: NDRA) has executed a definitive corporate merger agreement with Noble Africa (a subsidiary of ASP Isotopes). Under the cross-border financial engineering structure, Noble Africa will raise approximately $50 million via a private unit placement. The liquidity pool is ring-fenced to fund the immediate Phase 1 and Phase 2 commercial infrastructure developments of South African helium and LNG operator Renergen Limited at its Virginia Gas Project, shifting the listed vehicle's primary operations into upstream energy logistics.  #AfricaInvestorReview #CorporateMA #EnergyInfrastructure #HeliumMining #Renergen #Nasdaq #CapitalMarkets #FinancialEngineering https://lnkd.in/enfXP2iM